Beat The Denominator

The strategic partnership between Hims & Hers Health (HIMS) and Novo Nordisk (NVO) to sell branded GLP-1 weight-loss drugs marks a major shift toward a digital pharmacy model. Investors should consider HIMS as a high-growth disruptor with a long-term price target of $100, though they must be prepared for extreme volatility and price swings of up to 40%. The stock is currently primed for an "epic short squeeze," making it a high-conviction play for those looking to capitalize on forced buying from short sellers. Beyond weight loss, HIMS is diversifying into compounding with 14 new peptides and integrating AI to function more like a Big Tech platform than a traditional pharmacy. For broader exposure, Novo Nordisk (NVO) remains a top pick as it expands its distribution reach through these modern telehealth partnerships.

Investors should consider MicroStrategy (MSTR) as a high-conviction "flight-to-safety" play that is currently decoupling from broader market volatility. The company is aggressively using its "Stretch" (STRC) digital credit product to fund massive Bitcoin acquisitions, with a potential $1 billion buy announcement expected as early as next week. While Bitcoin prices have recently dipped, MSTR remains fundamentally undervalued as it utilizes its stock as a "printing press" to accumulate hard assets. Monitor Stretch.live to track real-time estimates of the company’s purchasing activity, which provides a significant liquidity floor for the entire crypto ecosystem. Given the bearish macro outlook and rising oil prices, MSTR offers a unique strategic hedge for those looking to outperform the general market.

Accumulate NVIDIA (NVDA) at current levels, as it is considered heavily undervalued and poised for a breakout once macroeconomic pressures ease. Tesla (TSLA) represents a high-conviction contrarian play, with strong business fundamentals suggesting a massive price surge if interest rates decline. Investors should look for recovery opportunities in beaten-down high-growth sectors like Hims & Hers Health (HIMS), which are currently trading at significant discounts. Allocate capital to Bitcoin (BTC) and Gold as essential "hard money" hedges against the long-term devaluation of the dollar and inevitable monetary printing. Position your portfolio for a "rates to zero" environment by prioritizing these high-growth tech stocks and hard assets to outperform inflationary trends.

Investors seeking high-beta exposure to Bitcoin (BTC) should prioritize MicroStrategy (MSTR), which currently acts as a leveraged "refinery" moving at roughly 1.5x the performance of the underlying asset. For more conservative participants, the new MSTR "Stretch" instrument offers a lower-volatility entry point into the ecosystem with an attractive yield of approximately 11.5%. Monitor the BTC Rating (Bitcoin held per share) to ensure the company's aggressive share offerings remain accretive and continue to grow the value of each share. With BTC recently breaking $73,000, the current supply-demand dynamic is highly favorable as institutional buying is effectively absorbing the entire daily global mining issuance. Use real-time tracking tools like Stretch.live to monitor capital flows, as continued aggressive acquisitions provide a significant price floor for the entire sector.

Consider a high-conviction position in The Real Brokerage Inc. (REAX), a disruptive real estate platform currently trading at a "dirt cheap" valuation relative to its 50-60% revenue growth. The company is a primary beneficiary of the anticipated Federal Reserve interest rate cuts in late 2024, which are expected to unlock sidelined housing inventory and drive transaction volume. Investors should focus on REAX over competitors like Open Door (OPEN) due to its superior "Rule of 40" efficiency and high-margin ancillary services like title insurance and mortgages. The business model specifically targets high-volume agents in growth states like Texas, California, and Florida, providing a structural advantage as the industry shifts toward lean, cloud-based brokerages. Monitor the company’s $150 million buyback facility and its expansion into AI-driven support as key catalysts for long-term scaling and profitability.

Investors seeking high yields with lower volatility should consider MicroStrategy’s "Stretch" (STRC), which targets a stable price of 100 and currently offers an 11.5% yield. This instrument is particularly attractive for high-income earners because it is structured as a "return of capital," potentially deferring taxes for up to nine years and rivaling the long-term returns of the NASDAQ. For direct crypto exposure, utilize a Dollar Cost Averaging (DCA) strategy in Bitcoin (BTC) to navigate "The Greatest Shake" and extreme sentiment swings. High-growth stocks like Hims & Hers (HIMS) and Duolingo (DUOL) present long-term opportunities for those who can stomach narrative-driven volatility, as these assets often rebound significantly after irrational sell-offs. Avoid over-reliance on traditional bonds and the 60/40 portfolio, instead shifting toward "digital credit" instruments that provide a more reliable hedge in the current macro environment.

Investors should prioritize Bitcoin (BTC) as a "risk-off" safe haven, as it is currently demonstrating superior resilience and outperforming the Nasdaq during periods of geopolitical instability. MicroStrategy (MSTR) offers a high-conviction way to play this trend, as the stock is successfully decorrelating from the struggling software sector (IGV) to trade in lockstep with digital assets. For a more defensive position, monitor the MicroStrategy Preferred Stock (STRC), which has maintained its value above the $100 level even when traditional bonds (BND) and energy stocks have failed to provide a hedge. Watch for STRC to trade above par as a signal that the company is aggressively using its "At-The-Market" program to acquire more Bitcoin, further boosting the ecosystem's value. Avoid traditional "flight-to-safety" plays like defense stocks or retail staples, which are currently underperforming and failing to act as reliable diversifiers in the current market environment.

Investors should consider Hims & Hers Health (HIMS) as a high-growth opportunity, with the stock currently viewed as undervalued following recent market volatility. The company is projected to see significant revenue growth of up to 33% by 2026, bolstered by the Eucalyptus acquisition and a robust subscription model for GLP-1 weight loss treatments. While legal battles with Novo Nordisk (NVO) persist, the impact is expected to be minimal until at least 2029, providing a long runway for current operations. Diversification into new peptides like BPC-157 offers a secondary growth catalyst that protects against potential shifts in the weight loss market. Monitor the FDA approval of Eli Lilly’s (LLY) Retatrutide, as this next-generation drug may eventually disrupt the demand for current compounded semaglutide offerings.

Bitcoin (BTC) is increasingly acting as a "risk-off" safe haven alongside gold, with strong institutional support established around the $67,000 level. Investors seeking high-growth exposure to this trend should consider MicroStrategy (MSTR), which uses its premium share price to aggressively accumulate more Bitcoin. For those prioritizing income, STRC offers an attractive 11% dividend increase and is currently in a high-growth phase as it raises capital above its critical $100 price threshold. Monitor the rapid growth of the APYX stablecoin, as its rising Total Value Locked signals increasing adoption of the broader Bitcoin credit ecosystem. This "Bitcoin Credit Revolution" presents a unique opportunity to move beyond simple holding and into yield-bearing instruments and decentralized finance.

Investors should consider MicroStrategy (MSTR) as a core holding due to its aggressive Bitcoin accumulation and expansion into European markets via new Exchange Traded Products. A high-conviction opportunity exists in Stretch (STRC), which recently increased its yield to 11.5%, a move expected to drive the asset to trade at par value consistently. International investors can capture even higher decentralized yields through the Apex stablecoin, which currently offers approximately 67% APY as it bridges capital into the STRC ecosystem. While Bitcoin (BTC) remains resilient, you should monitor oil prices and Middle East geopolitical tensions as the primary short-term risks to this bullish thesis. Look toward March for a broader macro recovery as the market begins pricing in a transition to a new Federal Reserve Chair.

Investors should view Bitcoin (BTC) as a resilient "risk-off" asset following its rapid V-shaped recovery to the $65,000 range despite geopolitical tensions. BTC remains a high-conviction long-term hold due to its fixed supply of 21 million and its unique status as a portable, unseizable asset during global conflicts. For immediate yield, the Stacks (STX) ecosystem offers a time-sensitive "gold rush" opportunity with yields up to 300% APY on the new APYUSD stablecoin protocol. Monitor MicroStrategy (MSTR) as a strategic proxy for Bitcoin, as it is expected to decouple from traditional software stocks and trade based on its digital asset holdings. Avoid over-exposure to physical commodities like Oil that face supply chain blockades, favoring "thermodynamically sound" digital protocols instead.

Investors should consider MicroStrategy (MSTR) as it shows significant relative strength against Bitcoin (BTC), currently trading at a high premium with a Market Net Asset Value of 1.22. For those seeking a yield-bearing alternative to traditional money market accounts, the MSTZ ("Stretch") instrument has cleared the psychological $100 level and is expanding into European markets and corporate treasuries. The current market sell-off has created potential overreaction entries in high-growth names like SoFi (SOFI) and Eos Energy (EOSE), which have seen massive price declines despite stable fundamentals. Specifically, EOSE may be an aggressive value play after being "halved" post-earnings, as the underlying business outlook remains intact. Monitor MSTR's active capital raises as a signal of continued BTC accumulation, which reinforces its position as a leveraged play on the digital asset's recovery.

Investors should view the current market rotation into defensive "value traps" like Walmart (WMT) and Coca-Cola (KO) as a buying opportunity for high-growth innovation leaders. NVIDIA (NVDA) remains the highest conviction long-term hold, as its fundamental AI growth far outweighs the perceived safety of government bonds. Bitcoin (BTC) is the primary hedge against inevitable currency debasement, serving as a "scarcity play" to protect wealth as the national debt increases. Look for efficiency-driven gains in Block (SQ) and PayPal (PYPL), specifically targeting companies using AI to aggressively reduce headcount and boost margins. Avoid long-term U.S. Treasuries, which are viewed as "return-free risk," and instead focus on Amazon (AMZN) and Tesla (TSLA) to capture the 30%+ revenue growth required to outpace inflation.

The recent 5% dip in NVIDIA (NVDA) is a prime buying opportunity, as the stock remains one of the cheapest high-growth plays in the Magnificent 7 ahead of the upcoming GTC conference and Ruben product launch. Zeta Global (ZETA) offers a high-conviction entry into AI-driven marketing, trading at a significant valuation discount despite guidance for 35% revenue growth through 2026. In the Buy Now, Pay Later sector, Sezzle (SEZL) continues to outperform traditional credit models, though investors may find better value in Klarna following its recent drawdown. Avoid "catching the falling knife" with Oddity Tech (ODD), as its growth thesis has collapsed; look to Hims & Hers (HIMS) for a more stable alternative in the direct-to-consumer space. For healthcare exposure, maintain a cautious Hold on TransMedix Group (TMDX), as slowing growth and long-term disruption from United Therapeutics (UTHR) limit its immediate upside.

With market sentiment in "extreme fear," now could be a favorable time for long-term investors to accumulate Bitcoin (BTC). For a leveraged investment, consider MicroStrategy (MSTR), which is presented as a buying opportunity on its recent dip. European investors seeking high yield can look into the new Bitcoin-backed "Stretch" ETP, trading under the ticker STRCNA on the Euronext Amsterdam exchange. Significant new demand for this product is also expected from DeFi integrations and corporate treasury adoption. Finally, fundamentally strong companies like Nvidia (NVDA) may be undervalued after being sold off with the broader market despite strong earnings.

A significant opportunity may exist in MicroStrategy's debt instruments like "strife" and "stride," which could potentially double in price to the $160-$200 range on a market "re-rating." This trade is based on the thesis that debt backed by a hard digital asset like Bitcoin will be valued more highly. The underlying asset, Bitcoin (BTC), also has a near-term bullish catalyst as the CME moves to 24/7 trading around May 29th. For investors seeking a simpler, leveraged bet on Bitcoin, MicroStrategy (MSTR) stock offers amplified exposure to its price movements. Analysts remain bullish long-term, with some maintaining a Bitcoin price target of ~$200,000 by year-end 2026.

Consider investing in Hims & Hers Health (HIMS), as the market appears to be misinterpreting its growth guidance. The company's official forecast excludes the upcoming Eucalyptus acquisition, which could add an unpriced $200 million in revenue and represent a significant near-term catalyst. The weight loss business is also more resilient than perceived due to its profitable oral medications, reducing reliance on the legally challenged GLP-1 market. For long-term growth in the pharmaceutical space, look at Eli Lilly (LLY), whose pipeline drug retatrutide is considered a potential blockbuster that could lead the next generation of weight loss treatments. The ultimate bull case for HIMS is its long-term potential to become a dominant, AI-driven direct-to-consumer healthcare platform.

Consider Hims & Hers (HIMS) as a compelling long-term investment, as the stock appears significantly undervalued relative to its rapid growth. The company is experiencing strong momentum, particularly in its "Hers" segment which is growing 100% year-over-year, and is showing a clear path to profitability with high gross margins. Current financial guidance is viewed as conservative and does not yet include the pending high-growth Eucalyptus acquisition, suggesting potential for a significant revenue beat. With a strong balance sheet and efficient marketing, the company is well-positioned to achieve its long-term revenue goal of $6.5 billion by 2030. Investors may find the current price an attractive entry point by looking past short-term market narratives.

Consider buying Amazon (AMZN), as its stock appears undervalued given its significant growth potential in grocery and Artificial Intelligence. In contrast, Walmart (WMT) may be overvalued as it faces a major long-term competitive threat from Amazon's expansion. Investors should be extremely cautious with telecom stocks like Verizon (VZ) and AT&T (T), which face fundamental disruption from satellite technology within the next 18 to 24 months. For long-term believers, Bitcoin (BTC) trading near $65,000 could present a buying opportunity, as its weakness is tied to broader market sentiment rather than its own fundamentals. Given the indiscriminate sell-off in high-growth stocks, exercising caution across the board is a prudent strategy until market conditions stabilize.

Consider the recent 25% price drop in Klarna (KLAR) as a significant buying opportunity, as the market seems to be misinterpreting its accounting and long-term growth. The "Buy Now, Pay Later" leader is considered undervalued, trading at just 1 times revenue despite a 26% growth rate and its disruption of the massive credit card industry. The recent earnings miss is attributed to conservative accounting rules that front-load potential losses, masking the company's strong underlying performance in revenue and user growth. An investment in KLAR is a high-conviction bet on the BNPL sector's continued takeover of market share from legacy players like American Express (AXP) and Visa (V). Long-term investors can view the stock's 71% decline from its highs as a chance to own a high-growth innovator at a discounted price.